Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Dips Bioscience is an Indian veterinary pharmaceutical company specializing in the manufacture and export of veterinary finished formulations, poultry premix vitamins, and animal feed supplements. Established in 2007 and headquartered in Maharashtra, the company produces a wide range of products including boluses, powders, sachets, and liquids in WHO GMP-certified facilities. Its portfolio features generic veterinary medicines such as albendazole, diminazene, and oxytetracycline, alongside feed enzymes like phytase and protease. Dips Bioscience serves global markets across Africa, Asia, and other regions, focusing on affordable animal healthcare and welfare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dips Biosciences.